register

News & Trends - MedTech & Diagnostics

Patient risk the priority in elective surgery reboot

Health Industry Hub | April 23, 2020 |

MedTech News: Patient safety and wellbeing is central to the staged return to elective surgery agreed by the National Cabinet, says Australian Private Hospitals Association’s (APHA) CEO Michael Roff.

“Private hospitals welcome the controlled return of elective surgery, which must be conducted so patients, health care workers and other hospital staff are as safe as possible. A phased reintroduction will allow hospitals to minimise risk to patients, monitor use of personal protective equipment (PPE) and ensure we maintain capacity in the system to address the pandemic if it is required.

“We must acknowledge the great work already done in the health care system and by Australians in flattening the curve and putting governments in a position to allow the reintroduction of some elective procedures.

“We agree with the National Cabinet’s approach and look forward to resuming surgeries that will have a dramatic effect on the quality of life for many Australians,” Mr Roff said.

Register FREE and join 22,000+ industry professionals receiving the latest industry news and engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

Mr Roff stressed the importance of access to PPE to ensure safety of patients and health care workers and that the use of PPE is appropriate to the procedure, in accordance with nationally developed guidelines.

“Access to PPE is going to be a critical issue for return to elective surgery and if normal supply chains are not restored soon, private hospitals will need to be given access either to government supply chains or to the national stockpile to ensure they can provide care safely.

“For a nationally consistent approach surgical restrictions need to be eased across the private and public hospitals at the same rate. This is to ensure equity of access to available services for patients on public elective waiting lists, in addition to privately insured patients.

“We must work together, going forward, to ensure Australians are able to get the care they need and our health workforce has the PPE needed to provide that care in a safe environment,” he said.

You may also like MedTech industry collaboration on PPE supply plays key role in elective surgery resumption

You may also like PRIME Awards 2020 call for entries – recognising excellence within Australian healthcare communications


News & Trends - MedTech & Diagnostics

Policy paralysis: Private hospitals left to clean up the government’s mess on medical device reforms

Policy paralysis: Private hospitals left to clean up the government’s mess on medical device reforms

Health Industry Hub | April 17, 2025 |

Hospitals shouldn’t be forced to grovel to private health insurers to secure funding for essential, lifesaving medical devices. But thanks […]

More


News & Trends - Pharmaceuticals

Oncologists pioneer liquid biopsy-guided treatment in lung cancer

Oncologists pioneer liquid biopsy-guided treatment in lung cancer

Health Industry Hub | April 17, 2025 |

Lung cancer is Australia’s leading cause of cancer deaths. Local experts are set to lead a new frontier in personalised […]

More


Medical and Science

The high cost of record low research funding

The high cost of record low research funding

Health Industry Hub | April 17, 2025 |

Australia has delivered some of the world’s most transformative health and medical breakthroughs – the cochlear implant, the HPV vaccine, […]

More


News & Trends - Pharmaceuticals

UCB secures dermatology indication with first dual IL-17A/F inhibitor

UCB secures dermatology indication with first dual IL-17A/F inhibitor

Health Industry Hub | April 17, 2025 |

UCB’s IL-17A and IL-17F inhibitor has been added to the Australian Register of Therapeutic Goods (ARTG) for adults with moderate […]

More


This content is copyright protected. Please subscribe to gain access.